Status:
COMPLETED
ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial
Lead Sponsor:
Kathmandu Medical College and Teaching Hospital
Conditions:
Cerebral Hemorrhage
Eligibility:
All Genders
20-100 years
Phase:
PHASE2
PHASE3
Brief Summary
Intracerebral hemorrhage is increasingly becoming a major burden in the society because of significant morbidity as well as mortality. Hematoma volume at the time of presentation as well as hematoma e...
Detailed Description
Patients and Methods: Data are being collected as patient gets admitted with Intracerebral haemorrhage. 154 spontaneous intracerebral haemorrhage patients presenting within 24 hours of ictus or last k...
Eligibility Criteria
Inclusion
- All patients presenting to the emergency department with symptom of hemorrhagic stroke within 24 hours from onset of symptom or last seen well.
- Patient who had a follow up
Exclusion
- Glasgow coma scale \<8 after resuscitation (as this can lead to biasness; requires surgery)
- Contraindication to tranexamic acid,
- Hemorrhagic stroke secondary to trauma,
- Hemorrhage was caused by coagulopathy
Key Trial Info
Start Date :
February 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2024
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT04742205
Start Date
February 8 2021
End Date
June 4 2024
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KMC Teaching Hospital, Kathmandu, Nepal
Kathmandu, Bagmati, Nepal, 44811